CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery

H. J. Benns, M. Storch, J. A. Falco, F. R. Fisher, Fabio Tamaki, E. Alves, C. J. Wincott, Rachel Milne, Natalie Wiedemar, G. Craven, Beatriz Baragaña, Susan Wyllie, Jake Baum, G. S. Baldwin, Eranthie Weerapana, Edward W. Tate, M. A. Child

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)
101 Downloads (Pure)

Fingerprint

Dive into the research topics of 'CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Chemistry